Cargando…

Jejunoileal atresia and cystic fibrosis: don’t miss it

BACKGROUND: While an increased prevalence of cystic fibrosis (CF) in patients with jejunal atresia and ileal atresia (JIA) has been described previously, it still may not be a practice routine to indicate a sweat test or DNA test for CFTR mutations in newborns presenting with JIA. Leading textbooks...

Descripción completa

Detalles Bibliográficos
Autores principales: Siersma, Carolien L, Rottier, Bart L, Hulscher, Jan BF, Bouman, Katelijne, van Stuijvenberg, Margriet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532316/
https://www.ncbi.nlm.nih.gov/pubmed/23217263
http://dx.doi.org/10.1186/1756-0500-5-677
_version_ 1782254287305310208
author Siersma, Carolien L
Rottier, Bart L
Hulscher, Jan BF
Bouman, Katelijne
van Stuijvenberg, Margriet
author_facet Siersma, Carolien L
Rottier, Bart L
Hulscher, Jan BF
Bouman, Katelijne
van Stuijvenberg, Margriet
author_sort Siersma, Carolien L
collection PubMed
description BACKGROUND: While an increased prevalence of cystic fibrosis (CF) in patients with jejunal atresia and ileal atresia (JIA) has been described previously, it still may not be a practice routine to indicate a sweat test or DNA test for CFTR mutations in newborns presenting with JIA. Leading textbooks do not mention JIA as a possible presenting clinical feature of CF. We describe two cases of JIA with a delayed diagnosis of CF (4 months [post mortem] and 19 months). This led to a retrospective review of all patients with JIA in our hospital. We hypothesised that also in the past although indicated further testing for CF had not always been performed. METHODS: Over an 18-year period from January 1991 until December 2008, all cases of JIA in our centre were reviewed (n=50). We compared patients who have been tested for CF (n=18) with patients who have not been tested for CF (n=32), with respect to their patient characteristics, either by logistic regression analysis or a nonparametric test (p<0.05). RESULTS: Of all 50 patients the proportion of infants actually tested for CF was 18 (36%). A statistical significant difference between the group of patients who were tested for CF versus the group of those who were not tested was found in a higher occurrence of postoperative bilious retention after 7 days (56% versus 25%, respectively), and postoperative complications (78% versus 34%, respectively). CF was confirmed in 4 (8%). CONCLUSION: Testing for CF in newborns presenting with JIA does not appear to be common practice. A timely diagnosis of CF leads to presymptomatic treatment and has beneficial effects on morbidity and mortality. CF should be tested for in all children with JIA. We recommend a sweat test for term children and CFTR DNA testing as a first step for preterm infants. Medical professional awareness may be increased if future editions of leading text books in the relevant fields should include JIA as an indication to follow an appropriate CF-diagnostic algorithm. TRIAL REGISTRATION: Statement on reporting of a clinical trial: This article is not based on a clinical trial.
format Online
Article
Text
id pubmed-3532316
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35323162013-01-03 Jejunoileal atresia and cystic fibrosis: don’t miss it Siersma, Carolien L Rottier, Bart L Hulscher, Jan BF Bouman, Katelijne van Stuijvenberg, Margriet BMC Res Notes Research Article BACKGROUND: While an increased prevalence of cystic fibrosis (CF) in patients with jejunal atresia and ileal atresia (JIA) has been described previously, it still may not be a practice routine to indicate a sweat test or DNA test for CFTR mutations in newborns presenting with JIA. Leading textbooks do not mention JIA as a possible presenting clinical feature of CF. We describe two cases of JIA with a delayed diagnosis of CF (4 months [post mortem] and 19 months). This led to a retrospective review of all patients with JIA in our hospital. We hypothesised that also in the past although indicated further testing for CF had not always been performed. METHODS: Over an 18-year period from January 1991 until December 2008, all cases of JIA in our centre were reviewed (n=50). We compared patients who have been tested for CF (n=18) with patients who have not been tested for CF (n=32), with respect to their patient characteristics, either by logistic regression analysis or a nonparametric test (p<0.05). RESULTS: Of all 50 patients the proportion of infants actually tested for CF was 18 (36%). A statistical significant difference between the group of patients who were tested for CF versus the group of those who were not tested was found in a higher occurrence of postoperative bilious retention after 7 days (56% versus 25%, respectively), and postoperative complications (78% versus 34%, respectively). CF was confirmed in 4 (8%). CONCLUSION: Testing for CF in newborns presenting with JIA does not appear to be common practice. A timely diagnosis of CF leads to presymptomatic treatment and has beneficial effects on morbidity and mortality. CF should be tested for in all children with JIA. We recommend a sweat test for term children and CFTR DNA testing as a first step for preterm infants. Medical professional awareness may be increased if future editions of leading text books in the relevant fields should include JIA as an indication to follow an appropriate CF-diagnostic algorithm. TRIAL REGISTRATION: Statement on reporting of a clinical trial: This article is not based on a clinical trial. BioMed Central 2012-12-07 /pmc/articles/PMC3532316/ /pubmed/23217263 http://dx.doi.org/10.1186/1756-0500-5-677 Text en Copyright ©2012 Siersma et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Siersma, Carolien L
Rottier, Bart L
Hulscher, Jan BF
Bouman, Katelijne
van Stuijvenberg, Margriet
Jejunoileal atresia and cystic fibrosis: don’t miss it
title Jejunoileal atresia and cystic fibrosis: don’t miss it
title_full Jejunoileal atresia and cystic fibrosis: don’t miss it
title_fullStr Jejunoileal atresia and cystic fibrosis: don’t miss it
title_full_unstemmed Jejunoileal atresia and cystic fibrosis: don’t miss it
title_short Jejunoileal atresia and cystic fibrosis: don’t miss it
title_sort jejunoileal atresia and cystic fibrosis: don’t miss it
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532316/
https://www.ncbi.nlm.nih.gov/pubmed/23217263
http://dx.doi.org/10.1186/1756-0500-5-677
work_keys_str_mv AT siersmacarolienl jejunoilealatresiaandcysticfibrosisdontmissit
AT rottierbartl jejunoilealatresiaandcysticfibrosisdontmissit
AT hulscherjanbf jejunoilealatresiaandcysticfibrosisdontmissit
AT boumankatelijne jejunoilealatresiaandcysticfibrosisdontmissit
AT vanstuijvenbergmargriet jejunoilealatresiaandcysticfibrosisdontmissit